Adult-onset diabetes, obesity cured in lab mice, scientists report
sciencedaily.com
sciencedaily.com
http://news.indiana.edu/releases/iu/2014/12/dimarchi-diabete...
Is equally useless, nearly a copy/paste. The older report, here:
http://news.indiana.edu/releases/iu/university-wide/2013/10/...
Makes it very clear that this is a treatment for diabetes, not a cure.
The most sure and certain finding of any preliminary study will be that more research is needed. All too often, preliminary findings don't lead to further useful discoveries in science, because the preliminary findings are flawed. The obligatory link for any discussion of a report on a research result like the one kindly submitted here is the article "Warning Signs in Experimental Design and Interpretation"[3] by Peter Norvig, director of research at Google, on how to interpret scientific research. Check each news story you read for how many of the important issues in interpreting research are NOT discussed in the story.
[1] "The Science News Cycle" http://www.phdcomics.com/comics.php?f=1174
[2] "Related by coincidence only? University and medical journal press releases versus journal articles" http://www.sciencebasedmedicine.org/index.php/related-by-coi...
[3] "Warning Signs in Experimental Design and Interpretation" http://norvig.com/experiment-design.html
P.S. The sparsity of details in the press release recycled by ScienceDaily reminds me of the many past complaints from Hacker News participants about the poor quality of ScienceDaily as a source. ScienceDaily is just a press release recycling service, nothing more. I learned from other participants here on HN that there are better sites to submit from.
Comments about ScienceDaily:
http://news.ycombinator.com/item?id=3992206
"Blogspam.
"Original article (to which ScienceDaily has added precisely nothing):
http://www.washington.edu/news/articles/abundance-of-rare-dn...
"Underlying paper in Science (paywalled):
http://www.sciencemag.org/content/early/2012/05/16/science.1...
"Brief writeup from Nature discussing this paper and a couple of others on similar topics:
http://www.nature.com/news/humans-riddled-with-rare-genetic-...
http://news.ycombinator.com/item?id=4108603
"Everything I've ever seen on HN -- I don't know about Reddit -- from ScienceDaily has been a cut-and-paste copy of something else available from nearer the original source. In some cases ScienceDaily's copy is distinctly worse than the original because it lacks relevant links, enlightening pictures, etc.
" . . . . if you find something there and feel like sharing it, it's pretty much always best to take ten seconds to find the original source and submit that instead of ScienceDaily."
Since these hormones don't change the genetic risk, it is a treatment which can have lasting effects, but unless obesity is suppressed, it is no cure. Also, the symptoms can happen without obesity and this wouldn't be a cure for them, but could be a treatment.
Anybody know otherwise?
"These preclinical studies suggest that, so far, this unimolecular, polypharmaceutical strategy has potential to be the most effective pharmacological approach to reversing obesity and related metabolic disorders."
Is anybody else getting a strong "too good to be true" vibe from all these unqualified superlatives?
"New single-cell molecules with triple-hormone action" sounds like somebody's already planning the marketing campaign.
- Sufficiently poor circulation to extremeties that they may require amputation - Progressive loss of vision - Kidney Failure - Increased risk of severe infection - Heart Disease (and death from it)
It is a fascinating statement on the human condition that research for medical methods of treatment that do not require a patient to try to alter their lifestyle or calorie intake receives so very much funding in comparison to, say, meaningful research into aging, or any one of hundreds of medical conditions in which the patient has absolutely no choice in the matter.
I agree, to an extend, but the reality is that there are a series of factors, besides the moral or 'self-evident' reasons, that make companies/governments fund these projects.
Moreover, forget about these factors for a second. The bottom line is that very few people would care if you found the cure for a very rare and destructive disease. Lots of people would pay a lot of money to avoid being fat.
And by the way, why exactly do you think that those lifestyle choices are easy to change? Very few people want to have diabetes (I assume). So there must be something else besides pure will that we should take into account when thinking about this issue.
Further, your uninformed opinion excludes people like myself who are thin but diabetic (type 2). It also excludes people who have LADA 1.5.
I guess because anyone who has diabetes is morally bankrupt they shouldn't expect any help. Is that right?
Further, your uninformed opinion excludes people like myself who are thin but diabetic (type 2). It also excludes people who have LADA 1.5.
The parent comment specifically stated that only the majority, not the entirety, of people with such conditions have them because of voluntary actions. Stop lying.
There are giant social costs stemming from obesity and T2 diabetes.
The above facts cause frustration for those of us not facing these issues.
For example, if my health insurance rate was based on my specific level of risk, I would likely pay 10% of my current premium. Yet, someone 150lbs heavier than me, same age, sex, etc. is much more likely to have health problems yet pays the same premium.
In other words, there is the perception that those who chose to create these problems aren't bearing the cost themselves, all of us are being forced to foot the bill.
(1)http://www.nytimes.com/2008/02/05/health/05iht-obese.1.97488...
And the argument that the longer lifespans of healthy people means they will consume more healthcare dollars sounds quite specious on the face of it. After all, healthy people do not have chronic conditions whereas the obese & smokers can spend 20-40 years being treated for hypertension, diabetes, heart failure, arthritis, emphysema, COPD, etc. How could people living, on average, an extra four to seven years without such chronic care possibly wind up costing more? As it turns out, the study you reference was not based on data from actual patient outcomes but is a mathematical model: http://www.plosmedicine.org/article/info%3Adoi%2F10.1371%2Fj...
David Strip calls into question the validity of the model thusly:
"Much in line with the response by Mittendorf, the validity of the results lies very strongly on key assumptions that are not demonstrated. The analysis assumes that the cost of an incidence of the 22 key diseases is independent of the risk factors being tested. Likewise, remaining health care costs, which account for 85% of health-care spending in the Netherlands , are assumed to be uncorrelated to risk factors. Given that this latter class of spending dwarfs the former, the importance of demonstrating the lack of correlation is particularly important. The incidence of numerous co-morbidities with obesity argues, in fact, that one might reasonably expect to find that the annual health costs are higher in the obese and that the cost of treatment in the last months preceding death may be quite different from the non-obese.
Kim McPherson, emeritus professor of public health at Oxford, wrote in response to the van Baal study here: http://www.plosmedicine.org/article/info%3Adoi%2F10.1371%2Fj...
In a sense, Van Baal and colleagues' study is a useful antidote to current concerns. But let us be clear: it does not attenuate them. Obese people cost less because individuals die younger and hence with less chronic morbidity associated with old age. This is a useful thing to know, but how might it affect public health strategies for obesity? In particular, does it mean that concerns about increasing population obesity are misplaced, as least as far as health-service costs are concerned?
Sadly not. Examine an obese population and a lean population of the same age and sex distribution, and the former will incur far greater health-care costs throughout the life course. Much more diabetes, and more cardiovascular disease and cancer will occur amongst the obese—even amongst the older obese [3]. Compare health-care costs now with those thirty years ago, and—holding everything but obesity constant—the current population costs much more to the health sector than it did then [4]. Moreover, quite apart from health-care costs, the other costs to society from obesity are also greater because of absences from work due to illness and employment difficulties; these costs amount to considerably more than health-care costs [5]. It is not clear that these extra costs are intrinsically related to health-care costs, but they are currently estimated to be around four times as great in obese than in lean people [5].